✦ LIBER ✦
386 POSTER Pharmacokinetic (PK) and pharmacodynamic (PD) phase I study of an oral c-Met inhibitor ARQ197 reaches maximum tolerated dose (MTD) in a twice daily (bid) dosing schedule
✍ Scribed by T.A. Yap; J. Barriuso; S. Frentzas; R. Riisnaes; J. Clark; J. Dukes; A. Futreal; R.E. Savage; F. Chai; J.S. de Bono
- Book ID
- 119599542
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 62 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.